Loss of c-KIT expression in thyroid cancer cells-Reference-Cited by-同舟云学术

Loss of c-KIT expression in thyroid cancer cells

Published:2017-03-16 Issue:3 Volume:12 Page:e0173913
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Franceschi Sara^ORCID,Lessi Francesca,Panebianco Federica,Tantillo Elena,La Ferla Marco,Menicagli Michele,Aretini Paolo,Apollo Alessandro,Naccarato Antonio Giuseppe,Marchetti Ivo,Mazzanti Chiara Maria

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence;A Czarniecka;Gland Surg,2016

2. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma;A Guerra;Thyroid,2014

3. Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation;AS Yamashita;Transl Oncol,2013

4. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma;M Zou;Thyroid,2014

5. Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome;M Sanlorenzo;J Proteomics,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FHL1: A novel diagnostic marker for papillary thyroid carcinoma;Pathology International;2024-08-09

2. The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature;Biochemistry and Biophysics Reports;2024-03

3. Thyroid cancer in Ecuador: A genetic variants review and a cross-sectional population-based analysis before and after COVID-19 pandemic;Heliyon;2024-01

4. c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights;OncoTargets and Therapy;2023-09

5. Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer;Immunity, Inflammation and Disease;2023-07